| 前收市價 | 32.40 |
| 開市 | 32.06 |
| 買盤 | 32.32 x 50000 |
| 賣出價 | 32.59 x 87000 |
| 今日波幅 | 31.97 - 32.70 |
| 52 週波幅 | 16.95 - 42.80 |
| 成交量 | |
| 平均成交量 | 1,202 |
| 市值 | 無 |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | 無 |
| 業績公佈日 | 2024年11月15日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
BenzingaUK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
The U.K. government has secured over 150,000 doses of the mpox vaccine from Bavarian Nordic A/S (OTC:BVNRY) (OTC:BVNKF) to strengthen the nation's defenses against clade I mpox. The vaccines will be distributed across the country, with the National Health Service (NHS) prioritizing individuals at higher risk of exposure to the virus. Almost two weeks ago, the European Commission said around 100,000 mpox vaccine doses arrived in the Democratic Republic of Congo (DRC), making these the first vacci
FortuneInside Bavarian Nordic: The $3.3 billion Danish pharma giant with the world’s only vaccine for mpox
Amid a new strain of mpox, the Danish company is preparing to make millions of vaccine doses to supply to the world.
Barrons.comMpox Outbreak Has the World on High Alert. What to Know.
A new strain of the virus appears to be spreading from the Democratic Republic of the Congo, where it was first identified last year.
